Zantac and Nolvadex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zantac (ranitidine hydrochloride) and Nolvadex (tamoxifen citrate). Common drug interactions include pain among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Zantac and Nolvadex. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.

What is Zantac?

Zantac has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 434,161 Zantac users. Check the latest studies of Zantac.

What is Nolvadex?

Nolvadex has active ingredients of tamoxifen citrate. It is often used in breast cancer. eHealthMe is studying from 5,506 Nolvadex users. Check the latest studies of Nolvadex.



On Jul, 18, 2026

93 people who take Zantac and Nolvadex together, and have interactions are studied.

Zantac and Nolvadex drug interactions.

What are the common drug interactions of Zantac and Nolvadex, by gender? *:

female:

  1. Pain
  2. Swelling face
  3. Spinal osteoarthritis (joint cartilage loss in spine)
  4. Pain in jaw
  5. Exostosis (formation of new bone on the surface of a bone)
  6. Oedema (fluid collection in tissue)
  7. Oedema peripheral (superficial swelling)
  8. Abdominal pain
  9. Fall
  10. Osteomyelitis (infection of bone)

male:

  1. Abdominal distension
  2. Abdominal pain
  3. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  4. Arthralgia (joint pain)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Asthenia (weakness)
  7. Asthma
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Atrioventricular block first degree (heart block first degree)
  10. Back pain

What are the common drug interactions of Zantac and Nolvadex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Scar
  2. Anxiety
  3. Injury
  4. Pain
  5. Arthralgia (joint pain)
  6. Back pain
  7. Bone disorder
  8. Cervical dysplasia (abnormal changes in the cells on the surface of the cervix)
  9. Cervix carcinoma (cancer of cervix)
  10. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Dental caries
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Leukopenia (less number of white blood cells in blood)
  8. Myalgia (muscle pain)
  9. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  10. Periodontitis (inflammation of the tissue around the teeth)

50-59:

  1. Diarrhoea
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Atypical femur fracture
  4. Pseudarthrosis (bones that do not heal after fracture)
  5. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  6. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  7. Anaemia (lack of blood)
  8. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  9. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

60+:

  1. Osteomyelitis (infection of bone)
  2. Back pain
  3. Arrhythmia (irregular heartbeat)
  4. Arthralgia (joint pain)
  5. Chest pain
  6. Depression
  7. Intervertebral disc protrusion (spinal disc protrusion)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Cataract (clouding of the lens inside the eye)
  10. Injury

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 29 people, 31.18%
  2. Breast Cancer Metastatic: 18 people, 19.35%
  3. Metastatic Neoplasm (spreadable cancer tumour): 16 people, 17.20%
  4. Sleep Apnea Syndrome: 12 people, 12.90%
  5. Hypersensitivity: 12 people, 12.90%
  6. Diabetes: 12 people, 12.90%
  7. Pain: 11 people, 11.83%
  8. Paget's Disease (disorder that involves abnormal bone destruction and regrowth, which results in deformity): 10 people, 10.75%
  9. Osteoporosis (bones weak and more likely to break): 10 people, 10.75%

* Approximation only. Some reports may have incomplete information.

Do you take Zantac and Nolvadex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zantac and Nolvadex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zantac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nolvadex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zantac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nolvadex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride and tamoxifen citrate (the active ingredients of Zantac and Nolvadex, respectively), and Zantac and Nolvadex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: